Avid Bioservices Inc (CDMO)

[Protector]

cheynew, that is incorrect. Plenty of terminated trials got approval. In their case because they perform sufficiently well at the look-in.

But the FDA is NOT involved in this termination. If the sponsor follows the advice because he thinks he has something by which he can make the data sufficient for a BLA (and I amply explained Dr. Garnick guarantees statement and Shan backing it up with some piratical example in answer to analysts) they I don't see what exactly the problem is.

And what is SHELVED! CEO King said STOPPED SUNRISE, TEMPORARY STOPPED other CHEMO+BAVI clinical trials.

That is all he said. His comments on focus on I-O are actually behind the fact of what PPHM was already doing with MSK, NCCN and AstraZeneca (with the possible exception of CHEM+Durvalumab+Bavituximab).

And cheynew, your 'grasping straws' statement is I think easily disproved because I posted a HUNDRED times at least: I WOULD PREFER PPHM NOT TO BE IN CHEMO+BAVI IF IT IS POSSIBLE and do ONLY I-O.

Under that flag I fail to see where the straw is in saying 2nd ln NSCLC Study is not death because that study is CHEMO+BAVI...just what I would NOT prefer.